Leukemia cells often display various mutations, for instance, the FMS-like tyrosine kinase 3 (FLT3)-internal tandem duplication (FLT3/ITD) mutation is observed in 30% AML [4,5]. This evidence concerns the gene FLT3 and leukemia.